NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 168 filers reported holding NOVOCURE LTD in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,109,346 | +82.5% | 15,124 | +89.1% | 0.01% | +50.0% |
Q3 2022 | $608,000 | +8.4% | 7,998 | -0.9% | 0.00% | +33.3% |
Q2 2022 | $561,000 | -14.4% | 8,072 | +2.2% | 0.00% | 0.0% |
Q1 2022 | $655,000 | +16.8% | 7,900 | +5.7% | 0.00% | 0.0% |
Q4 2021 | $561,000 | -35.4% | 7,475 | 0.0% | 0.00% | -25.0% |
Q3 2021 | $868,000 | -47.7% | 7,475 | -0.1% | 0.00% | -50.0% |
Q2 2021 | $1,659,000 | +67.9% | 7,480 | +0.1% | 0.01% | +60.0% |
Q1 2021 | $988,000 | -23.8% | 7,476 | -0.1% | 0.01% | -37.5% |
Q4 2020 | $1,296,000 | +56.0% | 7,487 | +0.2% | 0.01% | +60.0% |
Q3 2020 | $831,000 | +73.8% | 7,469 | -7.4% | 0.01% | +66.7% |
Q2 2020 | $478,000 | -5.0% | 8,069 | +8.0% | 0.00% | -25.0% |
Q1 2020 | $503,000 | -19.9% | 7,469 | +0.1% | 0.00% | 0.0% |
Q4 2019 | $628,000 | +12.5% | 7,458 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $558,000 | +19.2% | 7,458 | +0.8% | 0.00% | +33.3% |
Q2 2019 | $468,000 | +33.0% | 7,399 | +1.2% | 0.00% | +50.0% |
Q1 2019 | $352,000 | +43.7% | 7,312 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $245,000 | -45.4% | 7,312 | -14.7% | 0.00% | -33.3% |
Q3 2018 | $449,000 | +72.7% | 8,575 | +3.2% | 0.00% | +50.0% |
Q2 2018 | $260,000 | – | 8,312 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |